APLS vs REGN: Which Stock is Better?

Side-by-side comparison of Apellis Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

APLS

Apellis Pharmaceuticals Inc

$40.88

REGN

Regeneron Pharmaceuticals Inc

$742.08

Key Metrics Comparison

MetricAPLSREGNWinner
Market Cap$5.22B$79.87BREGN
P/E Ratio226.9418.21REGN
EPS (TTM)$0.18$41.48REGN
Revenue Growth-0.1%0.0%REGN
Gross Margin60.3%44.6%APLS

Analyze APLS

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APLS or REGN a better investment?

Comparing APLS and REGN: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APLS and REGN?

APLS (Apellis Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APLS or REGN?

Based on P/E ratios, REGN trades at a lower multiple (18.2x vs 226.9x).

Which is growing faster: APLS or REGN?

REGN has higher revenue growth at 0.0% vs -0.1% for APLS.

Which company is more profitable: APLS or REGN?

Apellis Pharmaceuticals Inc (APLS) has higher gross margins at 60.3% compared to 44.6% for REGN.

Which is the larger company: APLS or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $5.22B for APLS.

Should I buy APLS or REGN in 2026?

Both APLS and REGN have investment merit. APLS trades at $40.88 while REGN trades at $742.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APLS and REGN stock?

Key differences: Market Cap ($5.22B vs $79.87B), P/E Ratio (226.9x vs 18.2x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (60.3% vs 44.6%).

Popular Stock Comparisons